Dave Huizing - Koninklijke DSM Vice President Investor Relations
President
Mr. Dave Huizing has served as Vice President Investor Relations of Royal DSM NV since July 1, 2012. He started his career in DSM in 1985 as a lawyer. He held positions in Marketing Sales and Key Account Management for DSM Materials businesses, before moving into general management positions, latterly at the Value Assurance Review team. since 2012.
| Tenure | 12 years |
| Phone | 31 45 578 8111 |
| Web | https://www.dsm.com |
Koninklijke DSM Management Efficiency
The company has return on total asset (ROA) of 0.0402 % which means that it generated a profit of $0.0402 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1189 %, meaning that it generated $0.1189 on every $100 dollars invested by stockholders. Koninklijke DSM's management efficiency ratios could be used to measure how well Koninklijke DSM manages its routine affairs as well as how well it operates its assets and liabilities.Koninklijke DSM NV has accumulated 2.84 B in total debt with debt to equity ratio (D/E) of 0.31, which is about average as compared to similar companies. Koninklijke DSM NV has a current ratio of 2.46, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Koninklijke DSM until it has trouble settling it off, either with new capital or with free cash flow. So, Koninklijke DSM's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Koninklijke DSM NV sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Koninklijke to invest in growth at high rates of return. When we think about Koninklijke DSM's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Found 11 records | PRESIDENT Age | ||
| Lois ONeill | Dolphin Entertainment | 55 | |
| Michael Geraghty | Sensient Technologies | 62 | |
| Craig Mitchell | Sensient Technologies | 59 | |
| Barry Lowenthal | Inuvo Inc | 58 | |
| Nir Debbi | Global E Online | 50 | |
| Tobin Tornehl | Sensient Technologies | 50 | |
| Stephen Rolfs | Sensient Technologies | 59 | |
| Steve Morris | Sensient Technologies | 60 | |
| John Manning | Sensient Technologies | 55 | |
| Marilyn Laverty | Dolphin Entertainment | 70 | |
| Andrew Butcher | Luxfer Holdings PLC | 56 | |
Management Performance
| Return On Equity | 0.12 | |||
| Return On Asset | 0.0402 |
Koninklijke DSM NV Leadership Team
Elected by the shareholders, the Koninklijke DSM's board of directors comprises two types of representatives: Koninklijke DSM inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Koninklijke. The board's role is to monitor Koninklijke DSM's management team and ensure that shareholders' interests are well served. Koninklijke DSM's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Koninklijke DSM's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jan Wolters, Head Chemicals | ||
| Bruno Mller, Head Products | ||
| Paul Gilgen, Head Products | ||
| Manfred Eggersdorfer, VP Advocacy | ||
| Lieke JongTops, Communications Mang | ||
| Geraldine Matchett, CFO and Member of the Managing Board | ||
| Luca Rosetto, VP Products | ||
| Dimitri Vreeze, Member of the Managing Board | ||
| Dave Huizing, Vice President Investor Relations | ||
| Rob Atsma, Head Nederland |
Koninklijke Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Koninklijke DSM a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.12 | |||
| Return On Asset | 0.0402 | |||
| Profit Margin | 0.11 % | |||
| Operating Margin | 0.10 % | |||
| Current Valuation | 24.43 B | |||
| Shares Outstanding | 691.88 M | |||
| Shares Owned By Institutions | 0.15 % | |||
| Price To Earning | 38.86 X | |||
| Price To Book | 2.36 X | |||
| Price To Sales | 2.39 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Consideration for investing in Koninklijke OTC Stock
If you are still planning to invest in Koninklijke DSM NV check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Koninklijke DSM's history and understand the potential risks before investing.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Global Correlations Find global opportunities by holding instruments from different markets |